Editorial: Upadacitinib in Perianal Crohn's Disease. Authors' Reply [0.03%]
upadacitinib治疗周围性克罗恩病 作者答复
Nicolas Richard,Mathurin Fumery
Nicolas Richard
Letter: Lost in Translation-Replicating a Modifying FODMAP Diet in Patients With IBS. Authors' Reply [0.03%]
来信：翻译中的迷失——IBS患者修改FODMAP饮食的回复作者
María Fernanda Garcia-Cedillo,María Fernanda Huerta-de la Torre,Josealberto Sebastiano Arenas-Martinez et al.
María Fernanda Garcia-Cedillo et al.
Letter: Lost in Translation-Replicating a Modifying FODMAP Diet in Patients With IBS [0.03%]
致编辑：低碳饮食中的低FODMAP饮食疗法在肠易激综合征患者中再现及改良的问题
Emma P Halmos,Peter R Gibson
Emma P Halmos
Letter: Does the Association Between Mild Endoscopic Activity and Adverse Outcomes Justify Treatment Escalation in Older Adults With Inflammatory Bowel Disease? [0.03%]
来信：轻度内镜下炎症与不良预后之间的关系是否足以在老年炎性肠病患者中升级治疗？
Longwei Qiu,Junyi Tang,Chaochi Yue
Longwei Qiu
Letter: Low-FODMAP Diet in Irritable Bowel Syndrome-Beyond the Hype! Authors' Reply [0.03%]
关于肠易激综合征的低FODMAP饮食的意见及其回复作者的通知
María Fernanda Garcia-Cedillo,María Fernanda Huerta-de la Torre,Josealberto Sebastiano Arenas-Martinez et al.
María Fernanda Garcia-Cedillo et al.
Letter: A Histology-Defined Triple-Negative Phenotype of Primary Biliary Cholangitis [0.03%]
来信：原发性胆汁性胆管炎的三阴性表型的组织学定义
Shasha Li,Yu Zhang,Yuxiang Gong et al.
Shasha Li et al.
Letter: Upadacitinib in Perianal Crohn's Disease: Does Clinical Closure Reflect True Remission? [0.03%]
乌帕替尼治疗肛周克罗恩病：临床闭合反映真正的缓解了吗？
Glen Saward,Neel Heerasing
Glen Saward
Editorial: Two Common Risks, One Greater Harm-Diabetes and Alcohol in Steatotic Liver Disease. Authors' Reply [0.03%]
编者评论：两种常见的风险和更大的危害-糖尿病和酒精在脂肪肝病中的作用作者回复
Ruoqi Zhou,Yu Shi,Xinrong Zhang
Ruoqi Zhou
Editorial: Sleeve Gastrectomy Versus Lifestyle Intervention-Redefining the Therapeutic Hierarchy for Adolescent MASLD? [0.03%]
述评：袖状胃切除术与生活方式干预——重新定义青少年非酒精性 steatofibrosis 治疗的分层？
Ilias Papadimopoulos,Frank Tacke
Ilias Papadimopoulos